BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9021254)

  • 21. Amyotrophic lateral sclerosis brain banking: a proposal to standardize protocols and neuropathological diagnostic criteria.
    Cruz-Sánchez FF; Moral A; de Belleroche J; Rossi ML
    J Neural Transm Suppl; 1993; 39():215-22. PubMed ID: 8360661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced free radical generation of FALS-associated Cu,Zn-SOD mutants.
    Yim MB; Yim HS; Chock PB; Stadtman ER
    Neurotox Res; 1999 Dec; 1(2):91-7. PubMed ID: 12835105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation.
    Rubio A; Steinberg K; Figlewicz DA; MacDonald ME; Greenamyre T; Hamill R; Shoulson I; Powers JM
    Acta Neuropathol; 1996 Oct; 92(4):421-7. PubMed ID: 8891076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.
    Jain MR; Ge WW; Elkabes S; Li H
    Proteomics Clin Appl; 2008 May; 2(5):670-684. PubMed ID: 19578526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive review of amyotrophic lateral sclerosis.
    Zarei S; Carr K; Reiley L; Diaz K; Guerra O; Altamirano PF; Pagani W; Lodin D; Orozco G; Chinea A
    Surg Neurol Int; 2015; 6():171. PubMed ID: 26629397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS.
    Nardo G; Pozzi S; Mantovani S; Garbelli S; Marinou K; Basso M; Mora G; Bendotti C; Bonetto V
    Antioxid Redox Signal; 2009 Jul; 11(7):1559-67. PubMed ID: 19290778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics and Toxicity Analysis of Spinal-Cord Primary Cultures upon Hydrogen Sulfide Treatment.
    Greco V; Spalloni A; Corasolla Carregari V; Pieroni L; Persichilli S; Mercuri NB; Urbani A; Longone P
    Antioxidants (Basel); 2018 Jul; 7(7):. PubMed ID: 29996549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases.
    Cristofani R; Crippa V; Cicardi ME; Tedesco B; Ferrari V; Chierichetti M; Casarotto E; Piccolella M; Messi E; Galbiati M; Rusmini P; Poletti A
    Front Aging Neurosci; 2020; 12():191. PubMed ID: 32792938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis.
    Bowen BC; Pattany PM; Bradley WG; Murdoch JB; Rotta F; Younis AA; Duncan RC; Quencer RM
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):647-58. PubMed ID: 10782773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular mechanism of ALS and a possible gene therapy].
    Abe K; Warita H
    Rinsho Shinkeigaku; 1999 Jan; 39(1):68-9. PubMed ID: 10377808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications.
    Dal Canto MC
    Clin Neurosci; 1995-1996; 3(6):332-7. PubMed ID: 9021254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
    Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
    Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
    Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.